
Tommy Strong’s support advances CBTN’s tumoroid modeling and medulloblastoma classifier initiatives, critical building blocks for precision research and targeted therapies.

Tommy Strong’s support advances CBTN’s tumoroid modeling and medulloblastoma classifier initiatives, critical building blocks for precision research and targeted therapies.